Published in Nat Med on July 01, 2000
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 2.35
Central control of body weight and appetite. J Clin Endocrinol Metab (2008) 1.91
Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos Trans R Soc Lond B Biol Sci (2006) 1.72
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest (2014) 1.61
Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci U S A (2001) 1.55
Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. J Neurosci (2011) 1.54
Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci (2006) 1.47
Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci (2006) 1.27
Divergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats. Endocrinology (2007) 1.20
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol (2014) 1.16
Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2010) 1.11
GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes (2012) 1.03
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut (2004) 1.00
Intestinal hormones and growth factors: effects on the small intestine. World J Gastroenterol (2009) 0.98
GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. Am J Physiol Endocrinol Metab (2012) 0.95
Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons. Cell Metab (2013) 0.95
Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol (2006) 0.94
Gut adaptation and the glucagon-like peptides. Gut (2002) 0.93
Unraveling oxyntomodulin, GLP1's enigmatic brother. J Endocrinol (2012) 0.88
Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides. Endocrinology (2012) 0.84
The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. Am J Physiol Regul Integr Comp Physiol (2014) 0.84
GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab (2009) 0.82
Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization. Mol Biol Cell (2004) 0.81
Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain. J Biol Chem (2011) 0.81
Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disord (2014) 0.80
A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates. PLoS One (2013) 0.79
The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets. J Anim Sci Biotechnol (2016) 0.79
Research resource: Gene profiling of G protein-coupled receptors in the arcuate nucleus of the female. Mol Endocrinol (2014) 0.78
Gut Microbiota and Obesity. Curr Obes Rep (2012) 0.76
Glucagon-related peptides and the regulation of food intake in chickens. Anim Sci J (2016) 0.75
Appetite-Controlling Endocrine Systems in Teleosts. Front Endocrinol (Lausanne) (2017) 0.75
Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides. Front Endocrinol (Lausanne) (2017) 0.75
Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. PLoS One (2017) 0.75
Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature (1998) 2.99
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development (1996) 2.88
Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci (1995) 2.51
Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology (2001) 2.37
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol (1996) 2.17
Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology (1999) 1.97
Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol (1998) 1.95
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res (1995) 1.93
Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat Med (1997) 1.80
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol (1994) 1.79
Cancer invasion and tissue remodeling--cooperation of protease systems and cell types. APMIS (1999) 1.77
Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut (1999) 1.66
Neutrophils express tumor necrosis factor-alpha during mouse skin wound healing. J Invest Dermatol (1995) 1.60
The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem (1995) 1.45
Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci (1997) 1.40
Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis (1996) 1.27
Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight. Diabetes Obes Metab (2012) 1.21
Neurochemical characterization of hypothalamic cocaine- amphetamine-regulated transcript neurons. J Neurosci (1999) 1.20
Glucagon-like peptide containing pathways in the regulation of feeding behaviour. Int J Obes Relat Metab Disord (2001) 1.18
Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. J Mol Endocrinol (2005) 1.10
Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res (1999) 1.09
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut (2000) 1.08
Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab (1999) 1.05
A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors. Int J Cancer (1994) 1.04
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br J Pharmacol (2006) 1.02
Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary. Neuroendocrinology (1995) 1.01
Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut (1999) 1.00
Topographical organization of the rat suprachiasmatic-paraventricular projection. J Comp Neurol (1995) 0.99
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J (1991) 0.99
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol (2008) 0.98
Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology (2000) 0.98
Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit. J Neuroendocrinol (2003) 0.97
Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes (1998) 0.97
Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler (1995) 0.96
Origin of projections from the midbrain raphe nuclei to the hypothalamic paraventricular nucleus in the rat: a combined retrograde and anterograde tracing study. Neuroscience (1996) 0.95
Expression of Fos in the circadian system following nonphotic stimulation. Brain Res Bull (1998) 0.95
Neuropeptide Y inhibits hippocampal seizures and wet dog shakes. Brain Res (1996) 0.94
Light-dependent induction of cFos during subjective day and night in PACAP-containing ganglion cells of the retinohypothalamic tract. J Biol Rhythms (2001) 0.93
Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem (1991) 0.93
Central innervation of the rat ependyma and subcommissural organ with special reference to ascending serotoninergic projections from the raphe nuclei. J Comp Neurol (1997) 0.93
Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol (2002) 0.93
Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol (1995) 0.92
Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology (2000) 0.91
Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat. Neuroendocrinology (2001) 0.91
Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut (1998) 0.90
Plasminogen and wound healing. Nat Med (1996) 0.90
Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat Res (1994) 0.89
Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Obes Res (2000) 0.89
Cell cycle-dependent regulation of cellular ATP concentration, and depolymerization of the interphase microtubular network induced by elevated cellular ATP concentration in whole fibroblasts. Cell Motil Cytoskeleton (1996) 0.88
The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport (1999) 0.88
Enhanced masking response to light in hamsters with IGL lesions. J Comp Physiol A (1999) 0.87
Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling. Biochem J (2001) 0.87
The nude mouse as an in vivo model for human breast cancer invasion and metastasis. Breast Cancer Res Treat (1993) 0.87
Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress. J Neuroimmunol (1994) 0.87
A direct pretectosuprachiasmatic projection in the rat. Neuroscience (1994) 0.86
Revolutionary science: an improved running wheel for hamsters. Chronobiol Int (1998) 0.85
Effects of leptin on arcuate pro-opiomelanocortin and cocaine-amphetamine-regulated transcript expression are independent of circulating levels of corticosterone. J Neuroendocrinol (2002) 0.85
Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation. Brain Res (1996) 0.85
Insulin and glucose administration stimulates Fos expression in neurones of the paraventricular nucleus that project to autonomic preganglionic structures. J Neuroendocrinol (2001) 0.84
CART, a new anorectic peptide. Int J Biochem Cell Biol (1998) 0.84
Histaminergic activation of the hypothalamic-pituitary-adrenal axis. Endocrinology (1994) 0.84
Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons. Endocrinology (1994) 0.83
Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary. J Neuroendocrinol (1995) 0.83
Gating of retinal inputs through the suprachiasmatic nucleus: role of excitatory neurotransmission. Neurochem Int (1995) 0.83
Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience (2008) 0.83
Evidence for altered control of hypothalamic CRF in immune-mediated diseases. Ann N Y Acad Sci (1995) 0.83
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice. J Thromb Haemost (2007) 0.83
Gastrin releasing peptide in the rat suprachiasmatic nucleus: an immunohistochemical, chromatographic and radioimmunological study. Neuroscience (1991) 0.83
Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress (2000) 0.83
Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats. Diabetes Obes Metab (2009) 0.82
Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol (2001) 0.81
Evidence for the involvement of histaminergic neurones in the regulation of the rat oxytocinergic system during pregnancy and parturition. J Physiol (1997) 0.81
The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain. Eur J Pharmacol (1997) 0.81
Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats. Diabetes Obes Metab (2008) 0.81
Identification of NPY-induced c-Fos expression in hypothalamic neurones projecting to the dorsal vagal complex and the lower thoracic spinal cord. J Comp Neurol (2001) 0.81
Dehydration stimulates hypothalamic gene expression of histamine synthesis enzyme: importance for neuroendocrine regulation of vasopressin and oxytocin secretion. Endocrinology (1995) 0.80
PACAP gene expression in neurons of the rat hypothalamo-pituitary-adrenocortical axis is induced by endotoxin and interleukin-1beta. Neuroendocrinology (1999) 0.80
Direct link from the suprachiasmatic nucleus to hypothalamic neurons projecting to the spinal cord: a combined tracing study using cholera toxin subunit B and Phaseolus vulgaris-leucoagglutinin. Brain Res Bull (1997) 0.80
Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regul Pept (2003) 0.80
Proteoglycan expression in the normal rat kidney. Nephron (1997) 0.80
Higher physical activity is associated with increased androgens, low interleukin 6 and less aortic calcification in peripheral obese elderly women. J Endocrinol (2008) 0.80
Distribution of N-methyl D-aspartate (NMDA) receptor mRNAs in the rat suprachiasmatic nucleus. Brain Res (1993) 0.80
Substance P: multifunctional peptide in the hypothalamo-pituitary system? J Endocrinol (1992) 0.79
Involvement of histamine in suckling-induced release of oxytocin, prolactin and adrenocorticotropin in lactating rats. Neuroendocrinology (1996) 0.78
Substance p in the median eminence and pituitary of the rat: demonstration of immunoreactive fibers and specific binding sites. Neuroendocrinology (1989) 0.78
Pituitary adenylate cyclase activating peptide (PACAP) mRNA in the rat neocortex. Neurosci Lett (1994) 0.78
Persistence of nonphotic phase shifts in hamsters after serotonin depletion in the suprachiasmatic nucleus. Brain Res (1996) 0.78
Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Brain Res Mol Brain Res (1994) 0.78
The how and Y of eating. Nat Med (1998) 0.78
Neuronal histamine and expression of corticotropin-releasing hormone, vasopressin and oxytocin in the hypothalamus: relative importance of H1 and H2 receptors. Eur J Endocrinol (1998) 0.78
Neuronal projections from the mesencephalic raphe nuclear complex to the suprachiasmatic nucleus and the deep pineal gland of the golden hamster (Mesocricetus auratus). J Comp Neurol (1998) 0.78
Immunohistochemical and chromatographic identification of peptides derived from proneuropeptide Y in the human frontal cortex. Brain Res Bull (1993) 0.78
New therapeutic developments in the regulation of food intake by neuropeptides. Ann Endocrinol (Paris) (2002) 0.78